Navigation Links
Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
Date:5/3/2012

PARIS, May 3, 2012 /PRNewswire/ -- Marken announced today that it has acquired the European kit building operation from Laboratory Corporation of America® Holdings (LabCorp®) through its LabCorp Clinical Trials division. The new business located in Hamburg offers significant biological sampling kit building with experienced staff. This is the next step in Marken's strategy to provide a full supply chain service to its customers globally.

(Logo:  http://photos.prnewswire.com/prnh/20110930/NY78064LOGO

The business includes a facility that is currently able to produce up to 60,000 sampling kits each month for global distribution and its experienced staff including project leaders and Quality Assurance professionals will further strengthen Marken's comprehensive, global supply chain project and alliance management capability.

The transaction accompanies a master services agreement with LabCorp Clinical Trials for courier services and kit building supply for clinical trials in certain territories.

Wes Wheeler, Chief Executive Officer of Marken said, "This is an important day for Marken as it perfectly aligns with our global strategy as the leading provider in global life science supply chain solutions. The management and employee base provide unparalleled experience in clinical trial supply and biological sampling kit production."

"This innovative transaction continues our strategic focus on building our global clinical trials capabilities. LabCorp Clinical Trials division will continue to provide global laboratory testing services for our clients, aligning with Marken for kit production and full-service logistics capabilities," said Dr. David Johnston, Senior Vice President of LabCorp Clinical Trials. "As a result, we will provide a more cost effective way to provide the highest quality testing for our clients."

The Hamburg site will be led by Gerit Offenhauser, Senior Vice President of Clinical Trial Distribution for Marken who has extensive experience in central laboratory operations, kit building and related clinical logistics. Mr. Offenhauser has managed the Hamburg facility since 2004.

About Marken

Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies.

www.marken.com


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Validates Top Position in Global Clinical Sample Shipments
2. Marken Opens New Corporate Offices
3. Marken Strengthens Clinical Trial Distribution Capabilities
4. Marken Appoints New Head of Global Quality Assurance
5. Marken Announces Its New Logistics Operating System: Maestro™
6. Marken Announces Appointment of Christopher OConnell as New Chief Financial Officer
7. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
8. Marken Rapidly Responds to Global Supply Chain Security Measures
9. Marken Unveils New Japan Office
10. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
11. Piramal Healthcare Limited Acquires Molecular Imaging Development Portfolio of Bayer Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global artificial pancreas devices system market to grow at ... Artificial Pancreas Devices System Market 2016-2020, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:1/17/2017)... 2017 The interventional radiology products market is ... USD 6.35 billion in 2016, at a CAGR of ... this market are rising incidence of chronic diseases, rising ... The global interventional radiology products market is ... the basis of type, the stents segment is expected ...
(Date:1/17/2017)... , January 17, 2017 Management to ... TyrNovo, Ltd.   KIT-302 Development On Track For An ... FDA in Q1 2017   ... Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV ; TASE: KTOV), ... on Monday, January 23 rd at 8:30am Eastern Time to discuss the ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... ... Dr. Farhan Qureshi is an esteemed dentist who offers a full range of ... convenient office locations in Alexandria and Arlington, Virginia. Recently, Find Local Dentists has recognized ... This award confirms the fact that Dr. Qureshi’s patients have left highly favorable reviews ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Hear the World ... with the donation of cochlear implants. In February 2017, the first three children ... fair chance of leading an independent life. This engagement builds on the support ...
(Date:1/18/2017)... ... , ... Floundering on New Year’s resolutions? Need an excuse to get back ... The U.S. Apple Association agrees and recommends starting each day with apples, a ... heart disease. , The U.S. Apple Association – which represents apple growers and producers ...
(Date:1/17/2017)... ... 2017 , ... Gym Source, America’s leading retailer of premium residential and commercial ... in Miami, FL. , “We are elated to be opening this new showroom,” explains ... designed to give clients a seamless and motivating shopping experience.” , Every fitness journey ...
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... ... concerned by the political/social/economic events, Dr. Carol Francis re-releases powerfully uplifting interview with ... magical moments that help everyone endure and pass through tough times, Dr. Bernie ...
Breaking Medicine News(10 mins):